Comparative efficacy of long-acting muscarinic antagonists in preventing COPD exacerbations: a network meta-analysis and meta-regression - Yuji Oba, Nazir A. Lone, 2015
A randomized controlled trial of long-acting muscarinic antagonist and long- acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease | BMC Pulmonary Medicine | Full Text
Table 1 from Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. | Semantic Scholar
Long-acting Muscarinic Antagonists for Chronic Obstructive Pulmonary Disease – Knowledge Translation Program
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
Muscarinic Antagonists - AlphaNet
Revefenacin for COPD Patients With Suboptimal PIFR | Journal of The COPD Foundation
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis | Journal of Investigative Medicine
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Muscarinic Antagonist - an overview | ScienceDirect Topics
Breathe Better on Twitter: "If your doctor prescribes a long-acting muscarinic antagonist (LAMA) with an inhaled corticosteroid, make sure they explain how to use the inhaler properly because it's different than those
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial - The Lancet
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Long-Acting Muscarinic Antagonists (LAMAs) For Asthma
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Long-Acting Muscarinic Antagonists (LAMAs) | NHLBI, NIH
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Revefenacin for COPD Patients With Suboptimal PIFR | Journal of The COPD Foundation
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
